.Pharmacolibrary.Drugs.ATC.N.N05CH01_1 .Pharmacolibrary.Drugs.ATC.N.N05CH01_1| name: | Melatonin_1 |
| ATC code: | N05CH01_1 | route: | intravenous |
| n-compartments | 2 |
Melatonin is an endogenous hormone produced by the pineal gland involved in the regulation of circadian rhythms and sleep-wake cycles. As a drug, melatonin is primarily used to treat insomnia, jet lag, and circadian rhythm sleep disorders, and is available as an over-the-counter supplement in many countries. It is generally considered safe with limited adverse effects and is not approved as a prescription medication in most regions, but is widely used for sleep-related complaints.
Pharmacokinetic parameters following intravenous administration of 10 mg melatonin in healthy adult volunteers (both sexes).
Lalanne, S, et al., & Tordjman, S (2021). Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder. International journal of molecular sciences 22(3) –. DOI:10.3390/ijms22031490 PUBMED:https://pubmed.ncbi.nlm.nih.gov/33540815
Balduini, W, et al., & Buonocore, G (2019). Melatonin pharmacokinetics and dose extrapolation after enteral infusion in neonates subjected to hypothermia. Journal of pineal research 66(4) e12565–None. DOI:10.1111/jpi.12565 PUBMED:https://pubmed.ncbi.nlm.nih.gov/30734962
Bienert, A, et al., & Grześkowiak, E (2015). Melatonin and clonidine premedication has similar impact on the pharmacokinetics and pharmacodynamics of propofol target controlled-infusions. Journal of clinical pharmacology 55(3) 307–316. DOI:10.1002/jcph.401 PUBMED:https://pubmed.ncbi.nlm.nih.gov/25243731